What metabolic events cause mitochondrial swelling and depletion of glycogen granules in the ischemic region during an acute coronary occlusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Mitochondrial swelling and glycogen granule depletion in the ischemic region during an acute coronary occlusion are primarily caused by the shift from aerobic to anaerobic metabolism, leading to energy depletion, ionic disturbances, and acidosis. When blood flow is restricted, oxygen supply becomes inadequate, forcing cells to shift from aerobic to anaerobic metabolism, as noted in the context of myocardial infarction mechanisms 1. This metabolic switch causes rapid accumulation of lactic acid and hydrogen ions, creating an acidic environment that disrupts normal cellular function.

Key Metabolic Events

  • ATP production decreases dramatically as oxidative phosphorylation fails, leading to dysfunction of ATP-dependent ion pumps, particularly the Na+/K+ ATPase.
  • The resulting ionic imbalance causes sodium and calcium influx into cells, while potassium leaks out.
  • Calcium overload is especially damaging, as it enters mitochondria and triggers opening of the mitochondrial permeability transition pore, causing mitochondrial membrane depolarization, further impairing ATP production, and leading to mitochondrial swelling.
  • Simultaneously, glycogen stores are rapidly depleted as cells desperately attempt to generate ATP through glycolysis in the absence of oxygen, a scenario consistent with the pathophysiological mechanisms of myocardial infarction described in 1 and 1. The combination of energy depletion, ionic disturbances, and acidosis ultimately leads to cellular injury and, if prolonged, cell death in the affected myocardium.

From the Research

Metabolic Events Causing Mitochondrial Swelling and Depletion of Glycogen Granules

The metabolic events that most likely cause mitochondrial swelling and depletion of glycogen granules in the ischemic region during an acute coronary occlusion are:

  • Cessation of aerobic metabolism 2
  • Depletion of creatine phosphate (CP) 2
  • Onset of anaerobic glycolysis 2
  • Accumulation of glycolytic products, such as lactate and alpha glycerol phosphate (alpha GP) 2
  • Decrease in ATP levels and intracellular pH due to anaerobic metabolism and lactate accumulation 3
  • Dysfunction of ATPase-dependent ion transport mechanisms, contributing to increased intracellular and mitochondrial calcium levels (calcium overload) 3
  • Cell swelling and rupture due to calcium overload and dysfunction of ion transport mechanisms 3

Key Metabolic Changes

The key metabolic changes that occur during ischemia include:

  • Depletion of glycogen granules due to anaerobic glycolysis 2
  • Mitochondrial swelling due to calcium overload and oxidative stress 2, 3, 4
  • Accumulation of reactive oxygen species upon reperfusion, exacerbating ischemic injury 3

Biochemical Alterations

The biochemical alterations that occur during ischemia and reperfusion include:

  • Cellular acidosis and increase of inorganic phosphate levels 4
  • Alterations in ions and overall Ca2+ homeostasis 4
  • Oxidative stress mediated by oxygen free radicals 4
  • Membrane damage and irreversible deterioration of contractile function 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The cell biology of acute myocardial ischemia.

Annual review of medicine, 1991

Research

Cell biology of ischemia/reperfusion injury.

International review of cell and molecular biology, 2012

Research

Metabolic disturbances during myocardial ischemia and reperfusion.

The American journal of cardiology, 1995

Related Questions

What is the recommended duration for a patient to refrain from driving after being successfully treated with thrombolysis (fibrinolytic therapy) for acute coronary syndrome (ACS)?
What is the best course of action for a patient with a history of myocardial infarction, presenting with intermittent chest and leg pain, nausea, and impaired renal function, while on clopidogrel, dapagliflozin, sitagliptin, atorvastatin, gliglazide, amlodipine, and losartan?
What is the next step for a 62-year-old male patient with worsening shortness of breath, negative results for Acute Coronary Syndrome (ACS), normal stress test, normal echocardiogram, and normal Pulmonary Function Test (PFT)?
What is the treatment for a 65-year-old man with difficulty breathing and a respiratory rate (RR) showing a respiratory sinus arrhythmia (RSA) pattern in leads V2 and V3 on an electrocardiogram (ECG)?
What are the 2025 American College of Cardiology (ACC) and American Heart Association (AHA) guidelines for Acute Coronary Syndrome (ACS) management in emergency medicine?
What laboratory tests are recommended for a patient with anorexia?
What is the most appropriate initial CT scan to order for a patient presenting with intermittent headaches, radiation to the left eye, and transient visual changes: CTA, CT venogram, or CT head and brain?
When to recheck Complete Blood Count (CBC) in a patient with pneumonia and leukocytosis (White Blood Cell (WBC) count of 20)?
What is a cranioencephalic trauma (Traumatic Brain Injury - TBI)?
What is the management and treatment of a Gerbode defect?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.